Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | D3S-001 |
Trade Name | |
Synonyms | D3S001|D3S 001 |
Drug Descriptions |
D3S-001 inhibits KRAS G12C, potentially resulting in decreased tumor cell proliferation and tumor growth (J Clin Oncol 40, no. 16_suppl (June 01, 2022) e15102). |
DrugClasses | KRAS G12C inhibitor 34 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cetuximab + D3S-001 | Cetuximab D3S-001 | 0 | 0 |
D3S-001 | D3S-001 | 0 | 1 |
D3S-001 + D3S-002 | D3S-001 D3S-002 | 0 | 0 |
D3S-001 + Erdafitinib | D3S-001 Erdafitinib | 0 | 0 |